MRNA vs SER · rev $145.0M vs rev $56.0K
Moderna Inc (MRNA) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
MRNA currently screens at market cap $24.52B. SER currently screens at market cap $29.7M.
Not investment advice. Open the MRNA and SER stock pages for the full models.
Not investment advice.